Table_1.xls (5.5 kB)
Combinatory effects of gemcitabine and inhibitors targeting PI3K-Akt-mTOR pathway in human pancreatic and breast cancer cells.
dataset
posted on 2012-05-09, 00:31 authored by Junmei Hou, Liewei Wanga
The values represent the average of three independent experiments.
bIC50 values between combination treatment vs. Gem along were analyzed statistically by performing t tests.
Abbreviations: Gem, gemcitabine; TCN, tricirbine; Rap, rapamycin.